Phelan-McDermid Syndrome
Conditions
Brief summary
This is a pilot study examining the efficacy, safety and tolerability of intranasal oxytocin as a novel treatment in Phelan-McDermid syndrome (PMS). This study will utilize a randomized, placebo-controlled design for 12 weeks (phase 1), followed by an open-label extension for 12 weeks (phase 2). The purpose is to evaluate the effect of intranasal oxytocin on impairments in attention, social memory, socialization, language, and repetitive behaviors.
Interventions
Intranasal oxytocin
Placebo
Sponsors
Study design
Eligibility
Inclusion criteria
* Have a diagnosis of Phelan-McDermid syndrome defined by pathogenic deletion or mutation of the SHANK3 gene and confirmed by chromosomal microarray or sequencing. * Must be between the ages of 5 and 17 * Must be on stable medication and psychosocial therapy regimens for at least three months prior to enrollment
Exclusion criteria
* Allergy to oxytocin * Active cardiovascular disease, epilepsy, or renal disease that is not controlled by medication * Pregnant, lactating or refuse to practice contraception if sexually active * Have caretakers who are unable to speak English, be consistently present at visits to report on symptoms, or are otherwise judged unable to comply with the protocol by the study team * Comorbid conditions such that the patient is too medically compromised to participate
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Aberrant Behavior Checklist | Baseline and Week 12 | Change in scale at week 12 as compared to baseline. Aberrant Behavior Checklist - behavior rating subscales for the assessment of treatment effects.16 items, Each item is scored as 0 (never a problem), 1 (slight problem), 2 (moderately serious problem), or 3 (severe problem). Total score range from 0 to 48, with higher score indicating poorer health outcomes. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in Visual Paired Comparison (VPC) Task | Baseline and Week 12 | Change in VPC Task has 2 subscores at week 12 as compared to baseline. The subject is initially presented with a target for familiarization and the familiar target is then paired with a novel target. Recognition is indexed by a novelty score derived from the percentage of time looking at the novel stimulus vs. the familiar stimulus. The Social-Novel Preference score refers to the proportion of time spent looking at novel stimuli out of all the time spent looking at both novel and familiar stimuli in the social test. The Nonsocial-Novel Preference score refers to the proportion of time spent looking at novel stimuli out of all the time spent looking at both novel and familiar stimuli in the nonsocial test.The scores are given in proportions with a range from -1 to 1. A score of -1 would mean the participant shows a preference for familiar stimuli and a score of 1 demonstrates a preference for novel stimuli. |
| Change in Gap-Overlap Task | Baseline and Week 12 | One of three computerized eye tracking tasks to measure attention. three computer screens are set up side by side. A stimulus initially appears on the central screen, and once the participant orients to that stimulus, another stimulus will appear on one of the lateral screens. In the gap condition, the central stimulus will disappear before the peripheral stimulus appears. In the overlap condition, the central stimulus will remain on the screen while the peripheral stimulus appears. In both conditions, reaction times of the participant's eye movements (saccadic reaction time) from the central stimulus to the peripheral stimulus will be measured. Gap Effect measures the difference between average Gap and Overlap saccade latencies. |
| Change in Flicker Tasks | Baseline and Week 12 | One of three computerized eye tracking tasks to measure attention. The flicker task, or the four-alternative forced-choice preferential looking paradigm - the time interval over which the visual system is able to parse information. Scores range from -1 to 1 with higher scores indicating better (more typical) performance. |
| Change in Vineland Adaptive Behavior Scales | Baseline and Week 12 | Mean change in scale at week 12 as compared to baseline. Vineland Adaptive Behavior Communication Domain measures adaptive functioning. Vineland-II subdomains (Communication, Daily Living Skills, Socialization, Motor, Adaptive Behavior Composite, Internalizing, Externalizing and maladaptive) are V-scale scores (M=15, SD=3). Higher scores indicate better developed adaptive social behavior. Vineland-II domain and composite values are standard scores (M=100, SD=15). Higher scores indicate better developed adaptive social behavior. |
| Change in Repetitive Behavior Scale-Revised (RBS-R) | Baseline and Week 12 | Change in Repetitive Behavior Scale at week 12 as compared to baseline. the RBS-R is a 44-item self-report questionnaire consisting of subscales and one additional global rating score from 1-100. Score range for Stereotypic Behavior subscale is 0-27, Self-Injurious Behavior subscale is 0-24, Compulsive Behavior subscale is 0-18, Ritualistic/Sameness Behavior subscale is 0-36, and Restricted Interests subscale 0-9. Total scale for RBS-R is 0-214, with higher score indicating more severe problem. |
| Change in Clinical Global Impression - Severity Scales | Baseline and Week 12 | Mean Change in Clinical Global Impression-Severity Scales at week 12 as compared to baseline. Clinical Global Impressions (CGI) Rating Scales are commonly used to measure symptom severity and global improvement in treatment studies of patients with developmental disorders. There Severity Scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of illness at the time of assessment. Full scale from 1 - 7. Higher scores indicate greater symptom severity. |
| Change in Short Sensory Profile (SSP) | Baseline and Week 12 | Mean Change in Short Sensory Profile Scale at week 12 as compared to baseline, measuring sensory sensitivity and sensory seeking behavior. The SSP is a 38-item caregiver questionnaire. Items are based on a 5-point Liker scale ranging from 1=always to 5=never. Tactile Sensitivity ranges from 7-35. Taste/Smell Sensitivity ranges from 4-20. Movement Sensitivity ranges from 3-15. Underresponsive/Seeks Sensation ranges from 7-35. Auditory Filtering ranges from 6-30. Low Energy/Weak ranges from 6-30. Visual/Auditory Sensitivity ranges from 5-25. Total scale range from 38-190. Lower scores indicate a higher probability of sensory processing abnormalities. |
| Change in Macarthur-Bates Communicative Development Inventory (MCDI) | Baseline and Week 12 | Macarthur-Bates Communicative Development Inventory at week 12 as compared to baseline, measuring language. Words and Gestures Forms are for children ages 8-18 months. In the form, the first part prompts parents to document the child's understanding of hundreds of early vocabulary items separated into semantic categories such as animal names, household items, and action words. Parents mark the words understood or used, and the forms yield separate indexes of words understood and words produced. The second part of each form asks parents to record the communicative and symbolic gestures the child has tried or completed. Ranges for each subscale score are as follows: Phrases understood (0-28), Words understood (0-396), Words produced (0-396), Early gestures (0-18), Later gestures (0-45), Total gestures (0-63). Higher scores indicate a great number of words, phrases, or gestures understood or produced. |
| Change in EEG Tasks: Auditory Habituation | Baseline and Week 12 | In the Auditory Habituation EEG task, participants listen to a series of 4 tones and the neural responses to each of these tones (event related potentials, ERPs ) are averaged. The N1 and P2 components are typical responses to auditory stimuli. The N1 response is the initial, quick response to hearing a stimulus, and P2 reflects the later processing of the stimulus. Both of these should be greater in response to the first tone, and then reduce in response to each subsequent tone. This is known as habituation, and is calculated as the change in Tone 1 minus Tone 2 response for both N1 and P2 components. |
| Number of Adverse Events | week 12 | Number of Adverse Events through week 12 |
| Change in Caregiver Strain Index | Baseline and Week 12 | Mean Change Caregiver Strain Index at week 12 as compared to baseline. The Caregiver Strain Questionnaire is a 21-item measure of self-reported strain experienced by caregivers and families of youth with emotional problems, with responses on a 5-point Likert scale (0 = Not at all, 4 = very much). Full scale from 0 to 84, higher score indicates higher caregiver burden |
| Change in Mullen Scales of Early Learning (MSEL) | baseline and 12 weeks. | Change in Mullen Scales of Early Learning (MSEL) at week 12 as compared to baseline. The Mullen Scales results are reported using Age Equivalents, which provides an estimate of the chronological age (CA) in years and months at which a typically developing child demonstrates the skills displayed by the child being assessed. The Mullen Scales results are reported using T scores. (M = 100, SD = 15). Each subscale is standardized to calculate an age-equivalent score. Higher scores represent a higher CA, and therefore better outcome. |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Saline Then Oxytocin During the first phase, patients randomized to the placebo group received intranasal saline solution in doses of 24 IU two times daily, for a total of 48 IU. During the second phase of the study, all participants received intranasal oxytocin, in identical doses. | 10 |
| Intranasal Oxytocin The first phase of the study followed a double-blind, placebo-controlled design. Participants randomized to the experimental group received intranasal oxytocin started the trial with a dose of 24 international units (IU) twice daily (BID), which was adjusted to 12 IU BID, subsequently the dose was increased to 24IU BID. Each insufflation delivered 4 IU and three insufflations (12 IU) in each nostril were given twice daily for a total daily dose of 48 IU. The second phase was a 12-week open-label extension phase during which all participants received intranasal oxytocin. | 8 |
| Total | 18 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 |
|---|---|---|---|
| First Phase - 12 Weeks | Withdrawal by Subject | 3 | 1 |
Baseline characteristics
| Characteristic | Total | Intranasal Oxytocin | Saline Then Oxytocin |
|---|---|---|---|
| Aberrant Behavior Checklist Social Withdrawal (ABC-SW) subscale | 17.4 units on a scale STANDARD_DEVIATION 5.9 | 14. units on a scale STANDARD_DEVIATION 3.4 | 20.1 units on a scale STANDARD_DEVIATION 6.1 |
| Age, Continuous | 8.4 years STANDARD_DEVIATION 3.2 | 6.8 years STANDARD_DEVIATION 1.4 | 9.8 years STANDARD_DEVIATION 3.6 |
| Full Scale DQ | 21.4 T-score STANDARD_DEVIATION 14.5 | 26.3 T-score STANDARD_DEVIATION 16.7 | 17.4 T-score STANDARD_DEVIATION 11.8 |
| Nonverbal DQ | 22.7 T-score STANDARD_DEVIATION 12.3 | 26.1 T-score STANDARD_DEVIATION 13.1 | 20.1 T-score STANDARD_DEVIATION 11.7 |
| Race and Ethnicity Not Collected | 0 Participants | — | — |
| Sex: Female, Male Female | 9 Participants | 4 Participants | 5 Participants |
| Sex: Female, Male Male | 9 Participants | 4 Participants | 5 Participants |
| Verbal DQ - developmental quotient | 20 T-score STANDARD_DEVIATION 17.6 | 26.4 T-score STANDARD_DEVIATION 21.3 | 14.9 T-score STANDARD_DEVIATION 12.8 |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 10 | 15 / 15 |
| other Total, other adverse events | 9 / 10 | 15 / 15 |
| serious Total, serious adverse events | 0 / 10 | 0 / 15 |
Outcome results
Change in Aberrant Behavior Checklist
Change in scale at week 12 as compared to baseline. Aberrant Behavior Checklist - behavior rating subscales for the assessment of treatment effects.16 items, Each item is scored as 0 (never a problem), 1 (slight problem), 2 (moderately serious problem), or 3 (severe problem). Total score range from 0 to 48, with higher score indicating poorer health outcomes.
Time frame: Baseline and Week 12
Population: In the case of two participants who dropped out after week 4, difference scores were calculated for each outcome measure using the last observation carried forward (This is why some measures have N's of 9 and 7). Two participants dropped out after BL and were not included in the analysis.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Saline Then Oxytocin | Change in Aberrant Behavior Checklist | Irritability | -5 score on a scale | Standard Deviation 6.63 |
| Saline Then Oxytocin | Change in Aberrant Behavior Checklist | Hyperactivity | -8.11 score on a scale | Standard Deviation 11.85 |
| Saline Then Oxytocin | Change in Aberrant Behavior Checklist | Stereotypy | -2.22 score on a scale | Standard Deviation 4.66 |
| Saline Then Oxytocin | Change in Aberrant Behavior Checklist | Inappropriate speech | -1.67 score on a scale | Standard Deviation 3.04 |
| Saline Then Oxytocin | Change in Aberrant Behavior Checklist | Social Withdrawal | -7.44 score on a scale | Standard Deviation 4.58 |
| Intranasal Oxytocin | Change in Aberrant Behavior Checklist | Inappropriate speech | -7.14 score on a scale | Standard Deviation 2.21 |
| Intranasal Oxytocin | Change in Aberrant Behavior Checklist | Social Withdrawal | -2.42 score on a scale | Standard Deviation 3.15 |
| Intranasal Oxytocin | Change in Aberrant Behavior Checklist | Irritability | -1.71 score on a scale | Standard Deviation 7.13 |
| Intranasal Oxytocin | Change in Aberrant Behavior Checklist | Stereotypy | 0.57 score on a scale | Standard Deviation 2.99 |
| Intranasal Oxytocin | Change in Aberrant Behavior Checklist | Hyperactivity | -2.71 score on a scale | Standard Deviation 7.34 |
Change in Caregiver Strain Index
Mean Change Caregiver Strain Index at week 12 as compared to baseline. The Caregiver Strain Questionnaire is a 21-item measure of self-reported strain experienced by caregivers and families of youth with emotional problems, with responses on a 5-point Likert scale (0 = Not at all, 4 = very much). Full scale from 0 to 84, higher score indicates higher caregiver burden
Time frame: Baseline and Week 12
Population: incomplete form for one participant
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Saline Then Oxytocin | Change in Caregiver Strain Index | -1.83 score on a scale | Standard Deviation 1.47 |
| Intranasal Oxytocin | Change in Caregiver Strain Index | -0.86 score on a scale | Standard Deviation 1.07 |
Change in Clinical Global Impression - Severity Scales
Mean Change in Clinical Global Impression-Severity Scales at week 12 as compared to baseline. Clinical Global Impressions (CGI) Rating Scales are commonly used to measure symptom severity and global improvement in treatment studies of patients with developmental disorders. There Severity Scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of illness at the time of assessment. Full scale from 1 - 7. Higher scores indicate greater symptom severity.
Time frame: Baseline and Week 12
Population: Data from all participants who had data collected at 12 weeks.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Saline Then Oxytocin | Change in Clinical Global Impression - Severity Scales | -0.11 score on a scale | Standard Deviation 0.17 |
| Intranasal Oxytocin | Change in Clinical Global Impression - Severity Scales | -0.1 score on a scale | Standard Deviation 0.24 |
Change in EEG Tasks: Auditory Habituation
In the Auditory Habituation EEG task, participants listen to a series of 4 tones and the neural responses to each of these tones (event related potentials, ERPs ) are averaged. The N1 and P2 components are typical responses to auditory stimuli. The N1 response is the initial, quick response to hearing a stimulus, and P2 reflects the later processing of the stimulus. Both of these should be greater in response to the first tone, and then reduce in response to each subsequent tone. This is known as habituation, and is calculated as the change in Tone 1 minus Tone 2 response for both N1 and P2 components.
Time frame: Baseline and Week 12
Population: Data results available only for those who underwent Auditory Habituation EEG task
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Saline Then Oxytocin | Change in EEG Tasks: Auditory Habituation | Auditory Habituation: P2 Habituation Change | 1.15 microvolts (µV) | Standard Deviation 0.91 |
| Saline Then Oxytocin | Change in EEG Tasks: Auditory Habituation | Auditory Habituation: N1 Habituation Change | 0.05 microvolts (µV) | Standard Deviation 0.37 |
| Intranasal Oxytocin | Change in EEG Tasks: Auditory Habituation | Auditory Habituation: N1 Habituation Change | 0.12 microvolts (µV) | — |
| Intranasal Oxytocin | Change in EEG Tasks: Auditory Habituation | Auditory Habituation: P2 Habituation Change | -3.48 microvolts (µV) | — |
Change in Flicker Tasks
One of three computerized eye tracking tasks to measure attention. The flicker task, or the four-alternative forced-choice preferential looking paradigm - the time interval over which the visual system is able to parse information. Scores range from -1 to 1 with higher scores indicating better (more typical) performance.
Time frame: Baseline and Week 12
Population: Only 1 participant with data from baseline and Week 12
| Arm | Measure | Group | Value (MEAN) |
|---|---|---|---|
| Intranasal Oxytocin | Change in Flicker Tasks | Preference for the Target Box at 0.2 Hz | 0.10 score on a scale |
| Intranasal Oxytocin | Change in Flicker Tasks | Preference for the Target Box at 0.5 Hz | 0.30 score on a scale |
| Intranasal Oxytocin | Change in Flicker Tasks | Preference for the Target Box at 1 Hz | -0.12 score on a scale |
| Intranasal Oxytocin | Change in Flicker Tasks | Preference for the Target Box at 2 Hz | 0.03 score on a scale |
Change in Gap-Overlap Task
One of three computerized eye tracking tasks to measure attention. three computer screens are set up side by side. A stimulus initially appears on the central screen, and once the participant orients to that stimulus, another stimulus will appear on one of the lateral screens. In the gap condition, the central stimulus will disappear before the peripheral stimulus appears. In the overlap condition, the central stimulus will remain on the screen while the peripheral stimulus appears. In both conditions, reaction times of the participant's eye movements (saccadic reaction time) from the central stimulus to the peripheral stimulus will be measured. Gap Effect measures the difference between average Gap and Overlap saccade latencies.
Time frame: Baseline and Week 12
Population: Only 2 participants with data from both baseline and Week 12
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Saline Then Oxytocin | Change in Gap-Overlap Task | 63.81 milliseconds (ms) | Standard Deviation 34.19 |
Change in Macarthur-Bates Communicative Development Inventory (MCDI)
Macarthur-Bates Communicative Development Inventory at week 12 as compared to baseline, measuring language. Words and Gestures Forms are for children ages 8-18 months. In the form, the first part prompts parents to document the child's understanding of hundreds of early vocabulary items separated into semantic categories such as animal names, household items, and action words. Parents mark the words understood or used, and the forms yield separate indexes of words understood and words produced. The second part of each form asks parents to record the communicative and symbolic gestures the child has tried or completed. Ranges for each subscale score are as follows: Phrases understood (0-28), Words understood (0-396), Words produced (0-396), Early gestures (0-18), Later gestures (0-45), Total gestures (0-63). Higher scores indicate a great number of words, phrases, or gestures understood or produced.
Time frame: Baseline and Week 12
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Saline Then Oxytocin | Change in Macarthur-Bates Communicative Development Inventory (MCDI) | Phrases understood | 0.83 score on a scale | Standard Deviation 6.62 |
| Saline Then Oxytocin | Change in Macarthur-Bates Communicative Development Inventory (MCDI) | Words understood | -9.17 score on a scale | Standard Deviation 52.59 |
| Saline Then Oxytocin | Change in Macarthur-Bates Communicative Development Inventory (MCDI) | Words produced | 11.67 score on a scale | Standard Deviation 41.9 |
| Saline Then Oxytocin | Change in Macarthur-Bates Communicative Development Inventory (MCDI) | Early gestures | 1.83 score on a scale | Standard Deviation 2.64 |
| Saline Then Oxytocin | Change in Macarthur-Bates Communicative Development Inventory (MCDI) | Later gestures | 3 score on a scale | Standard Deviation 7.48 |
| Saline Then Oxytocin | Change in Macarthur-Bates Communicative Development Inventory (MCDI) | Total gestures | 4.83 score on a scale | Standard Deviation 9.97 |
| Intranasal Oxytocin | Change in Macarthur-Bates Communicative Development Inventory (MCDI) | Later gestures | 0.86 score on a scale | Standard Deviation 1.95 |
| Intranasal Oxytocin | Change in Macarthur-Bates Communicative Development Inventory (MCDI) | Phrases understood | 1.43 score on a scale | Standard Deviation 3.55 |
| Intranasal Oxytocin | Change in Macarthur-Bates Communicative Development Inventory (MCDI) | Early gestures | 0.29 score on a scale | Standard Deviation 1.38 |
| Intranasal Oxytocin | Change in Macarthur-Bates Communicative Development Inventory (MCDI) | Words understood | 7 score on a scale | Standard Deviation 13.41 |
| Intranasal Oxytocin | Change in Macarthur-Bates Communicative Development Inventory (MCDI) | Total gestures | 0.57 score on a scale | Standard Deviation 2.07 |
| Intranasal Oxytocin | Change in Macarthur-Bates Communicative Development Inventory (MCDI) | Words produced | 2.57 score on a scale | Standard Deviation 10.23 |
Change in Mullen Scales of Early Learning (MSEL)
Change in Mullen Scales of Early Learning (MSEL) at week 12 as compared to baseline. The Mullen Scales results are reported using Age Equivalents, which provides an estimate of the chronological age (CA) in years and months at which a typically developing child demonstrates the skills displayed by the child being assessed. The Mullen Scales results are reported using T scores. (M = 100, SD = 15). Each subscale is standardized to calculate an age-equivalent score. Higher scores represent a higher CA, and therefore better outcome.
Time frame: baseline and 12 weeks.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Saline Then Oxytocin | Change in Mullen Scales of Early Learning (MSEL) | Visual Reception | 0.29 T-score | Standard Deviation 7 |
| Saline Then Oxytocin | Change in Mullen Scales of Early Learning (MSEL) | Receptive Language | -1.86 T-score | Standard Deviation 4.86 |
| Saline Then Oxytocin | Change in Mullen Scales of Early Learning (MSEL) | Fine Motor | -0.29 T-score | Standard Deviation 1.11 |
| Saline Then Oxytocin | Change in Mullen Scales of Early Learning (MSEL) | Expressive Language | 0.43 T-score | Standard Deviation 2.61 |
| Saline Then Oxytocin | Change in Mullen Scales of Early Learning (MSEL) | Gross motor | -1.57 T-score | Standard Deviation 4.69 |
| Intranasal Oxytocin | Change in Mullen Scales of Early Learning (MSEL) | Expressive Language | 0.43 T-score | Standard Deviation 1.8 |
| Intranasal Oxytocin | Change in Mullen Scales of Early Learning (MSEL) | Gross motor | -0.86 T-score | Standard Deviation 1.46 |
| Intranasal Oxytocin | Change in Mullen Scales of Early Learning (MSEL) | Visual Reception | 2.86 T-score | Standard Deviation 3.3 |
| Intranasal Oxytocin | Change in Mullen Scales of Early Learning (MSEL) | Fine Motor | 0.71 T-score | Standard Deviation 1.8 |
| Intranasal Oxytocin | Change in Mullen Scales of Early Learning (MSEL) | Receptive Language | 1.71 T-score | Standard Deviation 2.7 |
Change in Repetitive Behavior Scale-Revised (RBS-R)
Change in Repetitive Behavior Scale at week 12 as compared to baseline. the RBS-R is a 44-item self-report questionnaire consisting of subscales and one additional global rating score from 1-100. Score range for Stereotypic Behavior subscale is 0-27, Self-Injurious Behavior subscale is 0-24, Compulsive Behavior subscale is 0-18, Ritualistic/Sameness Behavior subscale is 0-36, and Restricted Interests subscale 0-9. Total scale for RBS-R is 0-214, with higher score indicating more severe problem.
Time frame: Baseline and Week 12
Population: Patients were only included in this analysis if they had RBS-R at BL and Week 12
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Saline Then Oxytocin | Change in Repetitive Behavior Scale-Revised (RBS-R) | Compulsive behaviors | -1.56 score on a scale | Standard Deviation 3.09 |
| Saline Then Oxytocin | Change in Repetitive Behavior Scale-Revised (RBS-R) | Sameness behaviors | -2 score on a scale | Standard Deviation 2.65 |
| Saline Then Oxytocin | Change in Repetitive Behavior Scale-Revised (RBS-R) | Self-injury | -1.22 score on a scale | Standard Deviation 3.11 |
| Saline Then Oxytocin | Change in Repetitive Behavior Scale-Revised (RBS-R) | Restrictive behaviors | -1.43 score on a scale | Standard Deviation 2.39 |
| Saline Then Oxytocin | Change in Repetitive Behavior Scale-Revised (RBS-R) | Ritualistic behaviors | -1.33 score on a scale | Standard Deviation 2.4 |
| Saline Then Oxytocin | Change in Repetitive Behavior Scale-Revised (RBS-R) | Overall Score | -8.56 score on a scale | Standard Deviation 13.29 |
| Saline Then Oxytocin | Change in Repetitive Behavior Scale-Revised (RBS-R) | Stereotypic behaviors | -1.67 score on a scale | Standard Deviation 2.78 |
| Intranasal Oxytocin | Change in Repetitive Behavior Scale-Revised (RBS-R) | Overall Score | 0 score on a scale | Standard Deviation 5.56 |
| Intranasal Oxytocin | Change in Repetitive Behavior Scale-Revised (RBS-R) | Stereotypic behaviors | 0.29 score on a scale | Standard Deviation 2.87 |
| Intranasal Oxytocin | Change in Repetitive Behavior Scale-Revised (RBS-R) | Self-injury | 1 score on a scale | Standard Deviation 2.31 |
| Intranasal Oxytocin | Change in Repetitive Behavior Scale-Revised (RBS-R) | Compulsive behaviors | -0.14 score on a scale | Standard Deviation 0.69 |
| Intranasal Oxytocin | Change in Repetitive Behavior Scale-Revised (RBS-R) | Ritualistic behaviors | -0.43 score on a scale | Standard Deviation 1.62 |
| Intranasal Oxytocin | Change in Repetitive Behavior Scale-Revised (RBS-R) | Sameness behaviors | -0.29 score on a scale | Standard Deviation 1.6 |
| Intranasal Oxytocin | Change in Repetitive Behavior Scale-Revised (RBS-R) | Restrictive behaviors | 0.14 score on a scale | Standard Deviation 0.9 |
Change in Short Sensory Profile (SSP)
Mean Change in Short Sensory Profile Scale at week 12 as compared to baseline, measuring sensory sensitivity and sensory seeking behavior. The SSP is a 38-item caregiver questionnaire. Items are based on a 5-point Liker scale ranging from 1=always to 5=never. Tactile Sensitivity ranges from 7-35. Taste/Smell Sensitivity ranges from 4-20. Movement Sensitivity ranges from 3-15. Underresponsive/Seeks Sensation ranges from 7-35. Auditory Filtering ranges from 6-30. Low Energy/Weak ranges from 6-30. Visual/Auditory Sensitivity ranges from 5-25. Total scale range from 38-190. Lower scores indicate a higher probability of sensory processing abnormalities.
Time frame: Baseline and Week 12
Population: In the case of two participants who dropped out after week 4, difference scores were calculated for each outcome measure using the last observation carried forward (This is why some measures have N's of 9 and 7). Two participants dropped out after BL and were not included in the analysis.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Saline Then Oxytocin | Change in Short Sensory Profile (SSP) | Tactile | 2.56 score on a scale | Standard Deviation 5.17 |
| Saline Then Oxytocin | Change in Short Sensory Profile (SSP) | Auditory filtering | 4 score on a scale | Standard Deviation 5.68 |
| Saline Then Oxytocin | Change in Short Sensory Profile (SSP) | Movement | -0.67 score on a scale | Standard Deviation 2 |
| Saline Then Oxytocin | Change in Short Sensory Profile (SSP) | Low energy/weak | 1.67 score on a scale | Standard Deviation 6.18 |
| Saline Then Oxytocin | Change in Short Sensory Profile (SSP) | Taste/Smell | 1.67 score on a scale | Standard Deviation 2.88 |
| Saline Then Oxytocin | Change in Short Sensory Profile (SSP) | Visual/auditory sensitivity | 1.89 score on a scale | Standard Deviation 2.57 |
| Saline Then Oxytocin | Change in Short Sensory Profile (SSP) | Summary total | 14.33 score on a scale | Standard Deviation 21.31 |
| Saline Then Oxytocin | Change in Short Sensory Profile (SSP) | Under-responsive/seeks attention | 4.44 score on a scale | Standard Deviation 5.5 |
| Intranasal Oxytocin | Change in Short Sensory Profile (SSP) | Summary total | 1 score on a scale | Standard Deviation 17.95 |
| Intranasal Oxytocin | Change in Short Sensory Profile (SSP) | Visual/auditory sensitivity | -0.86 score on a scale | Standard Deviation 2.67 |
| Intranasal Oxytocin | Change in Short Sensory Profile (SSP) | Taste/Smell | 0.71 score on a scale | Standard Deviation 1.89 |
| Intranasal Oxytocin | Change in Short Sensory Profile (SSP) | Movement | 0.29 score on a scale | Standard Deviation 0.76 |
| Intranasal Oxytocin | Change in Short Sensory Profile (SSP) | Under-responsive/seeks attention | 0.71 score on a scale | Standard Deviation 4.68 |
| Intranasal Oxytocin | Change in Short Sensory Profile (SSP) | Auditory filtering | 0.29 score on a scale | Standard Deviation 5.21 |
| Intranasal Oxytocin | Change in Short Sensory Profile (SSP) | Low energy/weak | -0.71 score on a scale | Standard Deviation 4.19 |
| Intranasal Oxytocin | Change in Short Sensory Profile (SSP) | Tactile | 1.57 score on a scale | Standard Deviation 3.78 |
Change in Vineland Adaptive Behavior Scales
Mean change in scale at week 12 as compared to baseline. Vineland Adaptive Behavior Communication Domain measures adaptive functioning. Vineland-II subdomains (Communication, Daily Living Skills, Socialization, Motor, Adaptive Behavior Composite, Internalizing, Externalizing and maladaptive) are V-scale scores (M=15, SD=3). Higher scores indicate better developed adaptive social behavior. Vineland-II domain and composite values are standard scores (M=100, SD=15). Higher scores indicate better developed adaptive social behavior.
Time frame: Baseline and Week 12
Population: Participants were only included in this analysis if they had Vinelands at BL and Week 12. One incomplete Maladaptive subdomain form for one participant.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Saline Then Oxytocin | Change in Vineland Adaptive Behavior Scales | Communication | 4 score on a scale | Standard Deviation 7.72 |
| Saline Then Oxytocin | Change in Vineland Adaptive Behavior Scales | Daily Living Skills | 3.29 score on a scale | Standard Deviation 8.39 |
| Saline Then Oxytocin | Change in Vineland Adaptive Behavior Scales | Socialization | 3 score on a scale | Standard Deviation 4.86 |
| Saline Then Oxytocin | Change in Vineland Adaptive Behavior Scales | Motor | 1 score on a scale | Standard Deviation 3.46 |
| Saline Then Oxytocin | Change in Vineland Adaptive Behavior Scales | Adaptive Behavior Composite | 3.14 score on a scale | Standard Deviation 3.8 |
| Saline Then Oxytocin | Change in Vineland Adaptive Behavior Scales | Internalizing | -1.14 score on a scale | Standard Deviation 1.07 |
| Saline Then Oxytocin | Change in Vineland Adaptive Behavior Scales | Externalizing | -1.14 score on a scale | Standard Deviation 2.73 |
| Saline Then Oxytocin | Change in Vineland Adaptive Behavior Scales | Maladaptive | -1.33 score on a scale | Standard Deviation 2.42 |
| Intranasal Oxytocin | Change in Vineland Adaptive Behavior Scales | Maladaptive | 6 score on a scale | Standard Deviation 0.55 |
| Intranasal Oxytocin | Change in Vineland Adaptive Behavior Scales | Communication | 2.83 score on a scale | Standard Deviation 4.83 |
| Intranasal Oxytocin | Change in Vineland Adaptive Behavior Scales | Adaptive Behavior Composite | 2 score on a scale | Standard Deviation 3.22 |
| Intranasal Oxytocin | Change in Vineland Adaptive Behavior Scales | Daily Living Skills | 1.17 score on a scale | Standard Deviation 5.13 |
| Intranasal Oxytocin | Change in Vineland Adaptive Behavior Scales | Externalizing | 6 score on a scale | Standard Deviation 1.33 |
| Intranasal Oxytocin | Change in Vineland Adaptive Behavior Scales | Socialization | -0.5 score on a scale | Standard Deviation 4.46 |
| Intranasal Oxytocin | Change in Vineland Adaptive Behavior Scales | Internalizing | 6 score on a scale | Standard Deviation 0.84 |
| Intranasal Oxytocin | Change in Vineland Adaptive Behavior Scales | Motor | 3.17 score on a scale | Standard Deviation 6.18 |
Change in Visual Paired Comparison (VPC) Task
Change in VPC Task has 2 subscores at week 12 as compared to baseline. The subject is initially presented with a target for familiarization and the familiar target is then paired with a novel target. Recognition is indexed by a novelty score derived from the percentage of time looking at the novel stimulus vs. the familiar stimulus. The Social-Novel Preference score refers to the proportion of time spent looking at novel stimuli out of all the time spent looking at both novel and familiar stimuli in the social test. The Nonsocial-Novel Preference score refers to the proportion of time spent looking at novel stimuli out of all the time spent looking at both novel and familiar stimuli in the nonsocial test.The scores are given in proportions with a range from -1 to 1. A score of -1 would mean the participant shows a preference for familiar stimuli and a score of 1 demonstrates a preference for novel stimuli.
Time frame: Baseline and Week 12
Population: Only 3 participants with data from baseline and week 12
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Saline Then Oxytocin | Change in Visual Paired Comparison (VPC) Task | Social-Novel Preference | 0.01 score on a scale | — |
| Saline Then Oxytocin | Change in Visual Paired Comparison (VPC) Task | Nonsocial-Novel Preference | -0.38 score on a scale | — |
| Intranasal Oxytocin | Change in Visual Paired Comparison (VPC) Task | Social-Novel Preference | 0.02 score on a scale | Standard Deviation 0.12 |
| Intranasal Oxytocin | Change in Visual Paired Comparison (VPC) Task | Nonsocial-Novel Preference | 0.22 score on a scale | Standard Deviation 0.12 |
Number of Adverse Events
Number of Adverse Events through week 12
Time frame: week 12
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Saline Then Oxytocin | Number of Adverse Events | 41 events |
| Intranasal Oxytocin | Number of Adverse Events | 35 events |